NKGen Biotech (NKGN.US): Q4 2023 achieved revenue of $0; earnings per share of -$1.68.
NKGen Biotech(NKGN.US)：2023年Q4财报实现营收0美元；每股收益为-1.68美元。
NKGen Biotech (NKGN.US): Q4 2023 achieved revenue of $0; earnings per share of -$1.68.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.